Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Meibohm

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Journal of Hematology|August 19, 2014
TPO concentrations and response to romiplostimDavid J Kuter, Anne Meibohm, Angela Lopez
The Journal of Infection|November 24, 2012
Risk factors and outcomes of Candida krusei bloodstream infection: a matched, case-control studyMindy G Schuster, Anne Meibohm, Lisa Lloyd, et al.
The Journal of Antimicrobial Chemotherapy|May 20, 2004
Safety and tolerability of ertapenemHedy Teppler, Richard M Gesser, Ian R Friedland, et al.
Annals of Internal Medicine|February 7, 2018
Statistical Code to Support the Scientific StoryA Russell Localio, Steven N Goodman, Anne Meibohm, et al.
AIDS (London, England)|October 23, 2003
Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudineRoy M Gulick, Anne Meibohm, Diane Havlir, et al.
The Pediatric Infectious Disease Journal|December 3, 2009
Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccineStan L Block, Darron R Brown, Archana Chatterjee, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Journal of Hematology|August 19, 2014
TPO concentrations and response to romiplostimDavid J Kuter, Anne Meibohm, Angela Lopez
The Journal of Infection|November 24, 2012
Risk factors and outcomes of Candida krusei bloodstream infection: a matched, case-control studyMindy G Schuster, Anne Meibohm, Lisa Lloyd, et al.
The Journal of Antimicrobial Chemotherapy|May 20, 2004
Safety and tolerability of ertapenemHedy Teppler, Richard M Gesser, Ian R Friedland, et al.
Annals of Internal Medicine|February 7, 2018
Statistical Code to Support the Scientific StoryA Russell Localio, Steven N Goodman, Anne Meibohm, et al.
AIDS (London, England)|October 23, 2003
Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudineRoy M Gulick, Anne Meibohm, Diane Havlir, et al.
The Pediatric Infectious Disease Journal|December 3, 2009
Clinical trial and post-licensure safety profile of a prophylactic human papillomavirus (types 6, 11, 16, and 18) l1 virus-like particle vaccineStan L Block, Darron R Brown, Archana Chatterjee, et al.
Pageof 1